Initial Purchase/Additional Option | U.K. Doses (millions) | U.K. Treatments (millions) | U.S. Doses (millions) | U.S. Treatments (millions) | Canada Doses (millions) | Canada Treatments (millions) | EU Doses (millions) | EU Treatments (millions) |
---|---|---|---|---|---|---|---|---|
Moderna | 5 | 2.5 | 100/400 | 50/200 | 20 | 10 | 80/80* | 80/40 |
BioNTech/Pfizer | 30 | 15 | 100/500 | 50/250 | 20 | 10 | 200/100 | 100/50 |
Johnson & Johnson (Janssen) | 30/22 | 30/22 | 100/300 | 100/300 | 38 | 38 | 200/200 | 200/200 |
Oxford/AstraZeneca | 100 | 100 | - | - | 20 | 20 | 300/100 | 300/100 |
Novavax | 60 | 30 | 100 | 50 | 76 | 38 | - | - |
Sanofi/GSK | 60 | 30 | 100/500 | 50/250 | 72 | 36 | 300 | 150 |
CureVac | - | - | - | - | - | - | 225/180 | 112.5 |
Valneva | 60 | 30 | - | - | - | - | - | - |
Total | 345 / 367 | 237.5 / 259.5 | 500 / 2,200 | 300 / 1,300 | 246 | 152 | 1,305 / 1,785 | 302.5 / 1,292.5 |